opioid-induced constipation

Two years following US approval, Japan's Shionogi wins EU green light for opioid constipation drug
Two years following US approval, Japan's Shionogi wins EU green light for opioid constipation drug
Endpoints
Shionogi
Europe
opioid-induced constipation
Symproic
Rizmoic
Flag link:
When is bad press not so bad? When it's building a market, AstraZeneca says of its Super Bowl experiment
When is bad press not so bad? When it's building a market, AstraZeneca says of its Super Bowl experiment
Fierce Pharma
AstraZeneca
opioid-induced constipation
opioids
Flag link:
Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets
Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets
Yahoo
Valeant Pharmaceuticals
Progenics
Relistor
opioid-induced constipation
Flag link:
How Will AstraZeneca (AZN) Stock React to FDA's Movantik Approval?
How Will AstraZeneca (AZN) Stock React to FDA's Movantik Approval?
TheStreet.com
AstraZeneca
Movantik
FDA
opioid-induced constipation
Nektar
Flag link:
FDA approves AstraZeneca, Nektar constipation drug
FDA approves AstraZeneca, Nektar constipation drug
Yahoo/Reuters
FDA
AstraZeneca
Nektar
Movantik
opioid-induced constipation
Flag link:
AstraZeneca's Naloxegol Data Published
AstraZeneca's Naloxegol Data Published
Yahoo/Zacks
AstraZeneca
Naloxegol
opioid-induced constipation
Flag link:
FDA panel advises against large opioid-constipation drug safety trials
FDA panel advises against large opioid-constipation drug safety trials
Yahoo/Reuters
FDA
advisory panels
opioid-induced constipation
Flag link:
U.S. FDA advisors set to review opioid constipation drugs
U.S. FDA advisors set to review opioid constipation drugs
Yahoo/Reuters
FDA
opioid-induced constipation
Salix
Relistor
Cubist Pharmaceuticals
Entereg
AstraZeneca
Nektar
Naloxegol
Flag link:
Nektar Rises on FDA Notification
Nektar Rises on FDA Notification
Yahoo/Zacks.com
FDA
Nektar
AstraZeneca
Naloxegol
opioid-induced constipation
Flag link:
Sucampo Receives $10 Million Milestone Payment from Takeda on First Sale of AMITIZA® (lubiprostone) for OIC in the US
Sucampo Receives $10 Million Milestone Payment from Takeda on First Sale of AMITIZA® (lubiprostone) for OIC in the US
Yahoo
Sucampo
Takeda
Amitiza
opioid-induced constipation
Flag link:
AstraZeneca says Phase III studies of Naloxegol met primary, secondary endpoints
AstraZeneca says Phase III studies of Naloxegol met primary, secondary endpoints
The Fly on the Wall
AstraZeneca
Naloxegol
opioid-induced constipation
Flag link:
Sucampo Wins Approval for Expanded Use of Amitiza in U.S.
Sucampo Wins Approval for Expanded Use of Amitiza in U.S.
Bloomberg
Sucampo
Amitiza
opioid-induced constipation
Flag link:
Strength In Sucampo Heading Into FDA Decision And Analyst Activity
Strength In Sucampo Heading Into FDA Decision And Analyst Activity
Seeking Alpha
Sucampo
FDA
Rescula
Amitiza
opioid-induced constipation
Flag link: